money in cryptocurrency Featured

Ruifeng Optoelectronics: Hubei Ruihua, a wholly-owned subsidiary, received a government subsidy of 8,820,200 yuan. Ruifeng Optoelectronics announced that Hubei Ruihua Optoelectronics Co., Ltd., a wholly-owned subsidiary, recently received a loan interest subsidy of 8,820,200 yuan from the local finance of gedian Development Zone in Ezhou City, accounting for 19.20% of the company's audited net profit attributable to shareholders of listed companies in the latest fiscal year.Ziguang shares: Ziguang special account has reduced its holdings of 28.5 million shares, and Ziguang shares (000938.SZ) issued an announcement. As of December 9, 2024, Ziguang Group Co., Ltd.' s special account for property disposal of bankrupt enterprises (hereinafter referred to as "Ziguang special account") has reduced its holdings of 28.5 million shares through centralized bidding, accounting for 0.9965% of the company's total share capital, and the reduction price range is 2474 yuan/share. The reduction plan has been implemented.Shenwan Hongyuan Securities interprets the meeting of the Political Bureau in December: highlighting "expanding domestic demand in all directions" and "stabilizing the property market stock market". Shenwan Hongyuan Securities Research Report pointed out that in December, Politburo meeting of the Chinese Communist Party's discussion on next year's economic work was more refined, guiding the direction of future policies, such as "expanding domestic demand in all directions". The meeting rarely emphasized "stabilizing the property market and stock market", highlighting that the current policy pays more attention to the impact of asset-side performance on the real economy. The positive signal of the policy is being released continuously, and more specific deployment focuses on the upcoming Central Economic Work Conference in December. In terms of fiscal and monetary policies, the positive degree of macro-policy adjustment is relatively rare. The meeting proposed "implementing more positive and promising macro-policies" and "strengthening unconventional counter-cyclical adjustment". Under the "more active" fiscal policy, it may be worth looking forward to actively using the central deficit space that can be improved. Under the tone of "moderate easing", monetary policy may pay more attention to internal balance, and the RRR cut can be expected.

Reuters survey: 27 of 31 economists believe that the Swiss National Bank will cut interest rates by 25 basis points to 0.75% in December; Four people think that they will cut interest rates by 50 basis points; Fifteen of the 28 economists believe that the Swiss National Bank will cut the policy interest rate to 0.25% or lower by the end of 2025; 13 people think it will drop to 0.50% or higher.Merchants Shekou: In November, the contracted sales amount was 21.592 billion yuan. Merchants Shekou announced that in November 2024, the company realized the contracted sales area of 827,400 square meters and the contracted sales amount was 21.592 billion yuan. From January to November, 2024, the contracted sales area was 8,169,500 square meters, and the contracted sales amount was 189.063 billion yuan.Shenwan Hongyuan Securities interprets the meeting of the Political Bureau in December: highlighting "expanding domestic demand in all directions" and "stabilizing the property market stock market". Shenwan Hongyuan Securities Research Report pointed out that in December, Politburo meeting of the Chinese Communist Party's discussion on next year's economic work was more refined, guiding the direction of future policies, such as "expanding domestic demand in all directions". The meeting rarely emphasized "stabilizing the property market and stock market", highlighting that the current policy pays more attention to the impact of asset-side performance on the real economy. The positive signal of the policy is being released continuously, and more specific deployment focuses on the upcoming Central Economic Work Conference in December. In terms of fiscal and monetary policies, the positive degree of macro-policy adjustment is relatively rare. The meeting proposed "implementing more positive and promising macro-policies" and "strengthening unconventional counter-cyclical adjustment". Under the "more active" fiscal policy, it may be worth looking forward to actively using the central deficit space that can be improved. Under the tone of "moderate easing", monetary policy may pay more attention to internal balance, and the RRR cut can be expected.

Cube Pharmaceutical's mid-term profit distribution plan for 2024: It is planned to send 10 parties to 2 yuan. Cube Pharmaceutical disclosed its mid-term profit distribution plan for 2024 on the evening of December 9, and plans to distribute a cash dividend of 2 yuan (including tax) to all shareholders for every 10 shares. Based on this preliminary calculation, the company plans to distribute a total cash dividend of 38,252,100 yuan (including tax).At the evening peak, the security check of Guangzhou Metro resumed its previous process. At the evening peak of December 9, according to feedback from many citizens, the security check of Guangzhou Metro has resumed its previous security check process. Many netizens also said that they did not encounter the situation of queuing for security inspection when they entered the subway station after work. (South+)National Medical Products Administration publicly solicited opinions on the Announcement (Draft for Comment) on Simplifying the Registration and Approval of Traditional Oral Chinese Patent Medicines Listed in Hong Kong and Macao on the Mainland. According to the website of National Medical Products Administration, in order to implement the strategic plan of national construction in Guangdong-Hong Kong-Macao Greater Bay Area, further support the development of Chinese medicine in the Hong Kong Special Administrative Region and the Macao Special Administrative Region, and better integrate into the overall situation of national development, National Medical Products Administration drafted the Announcement (Draft for Comment) on Simplifying the Registration and Approval of Traditional Oral Chinese Patent Medicines Listed in Hong Kong and Macao on the Mainland, which is now open to the public for comments.